Concepedia

Octerloney B. McDonald

OB

21

Publications

2.2K

Citations

18

H-Index

1980

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

Duke University Hospital

Burroughs Wellcome Fund

Duke Medical Center

Octerloney B. McDonald is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1980–2018

21

Publications

21

A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib)

Edgar R. Wood, Anne T. Truesdale, Octerloney B. McDonald et al. · Cancer Research · 2004 · 1.1K citations · Full text

, , +20

The discovery of potent cRaf1 kinase inhibitors

Karen Lackey, Michael Cory, Ronda G. Davis et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 205 citations · Full text

, , +3

Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase

Nicholas D. Adams, Jerry L. Adams, Joelle L. Burgess et al. · Journal of Medicinal Chemistry · 2010 · 108 citations · Full text

, , +21

Heterogeneity of contractile proteins. A continuum of troponin-tropomyosin expression in mammalian skeletal muscle.

Frederick H. Schachat, D Bronson, Octerloney B. McDonald · Journal of Biological Chemistry · 1985 · 84 citations · Full text

Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors

Tara Rheault, Thomas R. Caferro, Scott H. Dickerson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 83 citations · Full text

, , +5

Rows per page

1–5 of 21